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 Transcription factors have been shown to play an impor-
tant role not only in the biology of photoreceptors and other
retinal cells, but also as sites of mutations causing degenera-
tive disease. For example, mutations in CRX and NRL cause
various forms of progressive retinal dystrophies [1-4]. The SP
family of transcription factors (SP1-5) is formed by a group
of proteins that selectively bind to the “GC box” in the pro-
moter region of many genes [5-7] via three putative zinc fin-
ger domains of the C2H2 type [8]. Based on sequence simi-
larities, SP1, SP3, and SP4 are more closely related to each
other than to SP2 and SP5 [6,9] and the three have similar
affinity for the GC box [10,11]. While SP1 and SP3 are ubiq-
uitously expressed, SP4 is most abundant in the developing
nervous system, particularly in the hippocampus [12] and retina
[13], although it is also expressed in other tissues [10,14]. Sp1
and Sp3 knockout mice all die after E10 or at birth, respec-
tively. Sp4 knockout mice appear to develop normally to birth,
but after birth, many pups die by P28 and those that survive
are small and have other abnormalities [12]. In the last few
years, we have studied extensively the SP4 transcription fac-
tor and have found that it is present in all retinal layers, inter-
acts with CRX and NRL and activates transcription of several
rod specific genes including PDE6B and RHO, encoding the
β-subunit of cGMP-phosphodiesterase (β-PDE) and rod op-
sin, respectively [13,15,16]. Because of its specific involve-
ment in transcription of rod genes and because of the history
of transcription factor mutations causing retinal degeneration,
we considered SP4 a good candidate gene to screen for mis-
sense mutations in patients with various forms of retinal de-
generation. To this end, we screened the 6 exons of the SP4
gene in a group of 270 patients with various forms of retinal
degeneration that had been screened previously for a number
of photoreceptor genes [17-21]. Although we could not estab-
lish that mutations in the SP4 gene cause retinal degenerative
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Purpose: SP4 is a transcription factor abundantly expressed in retina that binds to the GC promoter region of photorecep-
tor signal transduction genes. We have previously shown that SP4 may be involved in the transcriptional activation of
these genes alone or together with other transcription factors such as SP1, neural retina leucine zipper protein (NRL), and
cone-rod homeobox gene (CRX). Since mutations in NRL and CRX are involved in inherited retinal degenerations, SP4
was considered a good candidate for mutation screening in patients with this type of diseases. The purpose of this work,
therefore, was to investigate possible mutations in SP4 in a cohort of patients affected with different forms of retinal
degenerations.
Methods: 270 unrelated probands with various forms of retinal degeneration including autosomal dominant and autoso-
mal recessive retinitis pigmentosa (RP), autosomal dominant and autosomal recessive cone-rod dystrophy (CRD), and
Leber’s congenital amaurosis (LCA), were screened for mutations in the SP4 gene. Single strand conformation polymor-
phism (SSCP) analysis was performed on the six SP4 gene exons including flanking regions followed by direct sequenc-
ing of SSCP variants.
Results: Nine different sequence variants were found in 29 patients, four in introns and five in exons. Many of the
probands were previously screened for mutations in the genes encoding the α-, β- and γ-subunits of rod-specific cGMP
phosphodiesterase (PDE6A, PDE6B, PDE6G), the β-subunit of rod-specific transducin (GNB1), and peripherin/rds (RDS).
One group of seven probands of Hispanic background that included five with arRP, one with RP of unknown inheritance
(isolate) and 1 with arCRD carried an Asn306Ser mutation in SP4. Of the seven, the isolate case was homozygous and the
other 6 heterozygous for the variant. Two arRP and the arCRD probands carried an additional intronic GNB1 variant.
DNA from the family members of the arCRD proband could not be obtained, but for the other two families, all affected
members and none of the unaffected carried both the SP4 Asn306Ser allele and the GNB1 intronic variant.
Conclusions: If mutations in SP4 do cause retinal degenerative disease, their frequency would be low. While digenic
disease with the SP4 Asn306Ser and the GNB1 intronic variant alleles has not been established, neither has it been ruled
out. This leaves open the possibility of a cooperative involvement of SP4 and GNB1 in the normal function of the retina.
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287disease, neither could we rule this possibility out because the
families of two patients in which an SP4 missense mutation
and a GNB1 intron 2 variant were present, segregated with
disease. Interestingly, the inherited retinal degeneration of the
Rd4 mouse is caused by an inversion of mouse chromosome
4, and the site of the telomeric breakpoint is precisely on in-
tron 2 of the Gnb1 gene [22].
METHODS
Patients:  270 patient probands of mixed ethnicities (56% Eu-
ropean, 17% Asian, 13% Black, 14% Hispanic) were screened
for variants in the six exons of the SP4 gene, including 49
with autosomal dominant retinitis pigmentosa (adRP), 103 with
autosomal recessive retinitis pigmentosa (arRP), 26 with au-
tosomal dominant cone-rod dystrophy (adCRD), 52 with au-
tosomal recessive cone-rod dystrophy (arCRD), and 40 with
Leber’s congenital amaurosis (LCA). Many of the above pa-
tients had been previously screened for mutations in the genes
encoding rod- αPDE, βPDE, γPDE, rod β-transducin and RDS-
peripherin. 95 controls with a similar ethnic distribution (58%
European, 16% Asian, 13% Black, 13% Hispanic) were
screened for each of the above genes and SP4 as well. Written
informed consent was obtained in compliance with the tenets
of the declaration of Helsinki and with the approval of the
office of Human Research Protection of the School of Medi-
cine, University of California, Los Angeles.
Polymerase chain reaction:  Blood was drawn in 10-20
ml aliquots and DNA was extracted from the leukocytes by
standard methods. Initial screening was done by SSCP as de-
scribed previously [17-21]. The exons of SP4 were amplified
by polymerase chain reaction (PCR) directly from genomic
DNAs with appropriate primers pairs. Each PCR amplicon
included 50-150 nt of intronic flanking sequence on each side
of the exon. The PCR protocol was 94 °C for 3 min followed
by 30 cycles of 94 °C for 45 s, 55-60 °C for 45 s and 72 °C for
45 s, followed by 5 min at 72 °C. The sequences of primer
pairs are presented in Table 1.
Single strand conformation polymorphism:  Amplicons
were separated by electrophoresis in 7% acrylamide gels and
analyzed by standard P32 autoradiography or silver staining
methods to reveal polymorphisms as described previously [17-
21].
Sequencing:  Amplicons carrying polymorphisms were
purified using the QIA QUICK PCR purification kit (Qiagen,
Valencia, CA) and sequenced using the Dyenamic ET Termi-
nator cycle sequencing kit (Amersham, Piscataway, NJ).
RESULTS
 SSCP screening of the SP4 gene showed 9 sequence variants
in 29 patients, five present in exons (Table 2). The heterozy-
gous Leu241Val and Pro286Ala missense variants, both
present in exon 3 of arRP probands did not segregate with
disease in the corresponding families. An Asn306Ser missense
variant in exon 3 was present in both alleles of one isolate RP
proband, in one allele of five arRP probands and in one arCRD
proband. This missense variant was also present in 1/95 con-
trols. Interestingly, although only 14% of the 270 patients and
13% of the 95 controls were Hispanic, all seven patients and
the 1 control that carried Asn306Ser were Hispanic. Thus,
18.4% (7/38) of the Hispanic patients carried Asn306Ser while
none of the other patients did, including 0/151 patients of Eu-
ropean origin. The other 2 coding region variants were both
silent. Neither was present in 95 controls. The remaining 4
intronic sequence variants were present in patients and absent
from controls with the exception of -121 A to C which was
present in one control (Table 2).
Table 3 shows the results of previous screenings of sev-
eral photoreceptor genes in the six probands with the
Asn306Ser mutation in one allele. Patient 856 has arCRD while
the other 5 patients have arRP. Three of the six probands also
carried an A-G variant in intron 2 of the GNB1 gene. DNAs of
the family members of one of these probands could not be
obtained (family 2177). However, in the families of the other
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TABLE 1. PRIMER SEQUENCES USED FOR SP4 AND GNB1 SCREENING
In each primer pair of this table F indicates the forward primer an-
nealing to the DNA in the 5'-3' direction and R indicates the reverse
primer, annealing to the DNA in the 3'-5' direction. Since exon three
of SP4 is long, six sets of primer pairs were used for its amplifica-
tion.
TABLE 2. SEQUENCE VARIANTS DETECTED IN THE SCREENING OF THE
SP4 GENE
All sequence variants present in the coding region of SP4 were found
in exon three. The only SP4 variant that segregated with disease was
Asn306Ser.
288two probands, the SP4 missense and the GNB1 intronic vari-
ant segregated with disease (Figure 1A,B). None of the other
variants in the screened genes segregated with disease. We
found no additional variants in the genes encoding α-, β- and
γ-cGMP-phosphodiesterase, RDS/peripherin or the β-subunit
of transducin in the RP isolate patient homozygous for
Asn306Ser.
DISCUSSION
 Even though 2/3 of mice born with the Sp4 gene deleted die
within the first four weeks of life [14], the surviving mice
have many abnormalities including severe retinal degenera-
tion (our data, not shown). Therefore, we considered the hu-
man SP4 gene a good candidate for the site of missense muta-
tions causing retinal degeneration, given its involvement in
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TABLE 3. SEQUENCE VARIANTS IN FIVE GENES OF SIX PATIENTS WITH THE HETEROZYGOUS SP4 ASN306SER MUTATION
The probands of three families (485, 1526, and 2177) had an intronic sequence variant in GNB1 in addition to SP4 Asn306Ser. These sequence
variants segregated with disease in families 485 and 1526. We were unable to obtain the DNA of members of family 2177. The sequence
variant in intron 18 of PDE6A did not segregate with disease in families 485 and 1526.
289the transcription of several photoreceptor genes including
PDE6B [13,15,16] and the phenotype of the Sp4 knockout
mouse.
We found nine unique sequence variants in the SP4 gene
of 29 patients affected with different types of inherited retinal
degenerative disease. Of these, five variants were in one of
the six exons of SP4. Two of the variants coded for the same
amino acid (Ala276Ala and Gln451Gln). Two more variants
predicted amino acid changes in the SP4 protein, Leu241Val
and Pro286Ala, but neither segregated with disease in the cor-
responding families. The fifth missense Asn306Ser mutation
was present in seven probands. One of the probands that had
the homozygous Asn306Ser mutation was an isolate with RP,
so we could not tell if the two Asn306Ser alleles were causing
disease. In family 449, an affected sibling of the proband did
not carry the Asn306Ser allele; for the probands of families
856 (arCRD) and 1824, neither a second variant SP4 allele
nor a variant in any of the other genes previously screened
could be identified. The three remaining probands all carried
Asn306Ser and an intronic A-G substitution 103 bp upstream
of the 3' splice site of intron 2 of the GNB1 gene. We could not
obtain DNAs from the family of one of the probands (2177),
but in the families of the other two probands (485 and 1526)
only the two affecteds in each pedigree carried both alleles
(Figure 1A,B). Both of these families had arRP. All seven fami-
lies carrying Asn306Ser were of Hispanic background and so
was the 1 control carrying the same mutation. Thus, 18.4% of
the Hispanic patients carried this allele while none of the pa-
tients from other backgrounds did (0/151 Europeans, 0/35
Blacks and 0/46 Asians). The higher frequency of Asn306Ser
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Figure 1. Pedigrees number 485 and number 1526 segregate the SP4/
GNB1 alleles.  Filled symbols indicate individuals with retinitis
pigmentosa. Probands are indicated by arrows. The allele designa-
tion SP4 denotes the Asn306Ser allele, GNB1 denotes the A-G sub-
stitution in intron 2 of the GNB1 gene, + denotes normal alleles.
Figure 2. Partial nucleotide se-
quence of the cDNA encoding
human SP4 and the corre-
sponding predicted amino acid
sequence.  Boxes indicate po-
tential N-glycosylation sites
(N-X-S/T). Asterisk (*) indi-
cates the location of the A to G
mutation (AAC to AGC causes
the change of Asn306 to Ser).
290in Hispanic patients (p<0.001 applying the Fisher’s exact test)
compared to a relatively low frequency in Hispanic controls
(1/12=8.3%) suggests that this variant may be pathogenic.
There are several additional reasons that implicate SP4
Asn306Ser as a mutant allele that may contribute to autoso-
mal recessive disease. (1) We have no family history for the
proband that carried two alleles of Asn306Ser. Therefore, the
two Asn306Ser alleles together could be the cause of that iso-
late patient’s disease. (2) In each of the three families where
the Asn306Ser allele did not segregate with disease, two mu-
tant alleles in other genes may have rendered the presence of
the heterozygous Asn306Ser coincidental and unrelated to dis-
ease. However, this does not rule out the possibility that two
Asn306Ser alleles could cause disease. (3) For the two fami-
lies where only the affecteds carried both the Asn306Ser al-
lele and the GNB1 variant intronic allele, pathogenesis is pos-
sible at least genetically. Furthermore, GNB1 has three GC
boxes in its promoter and SP4 interacts with GC boxes. Thus,
digenic disease may be plausible. To answer the question of
pathogenicity of Asn306Ser, functional assays of the protein
carrying this variant would have to be conducted. Neverthe-
less, the possibility that Asn306Ser may be pathogenic is sup-
ported by the fact that Asn306Ser is in the transactivation do-
main of the SP4 protein and in one of six glycosylation sites
(N-X-S/T; Figure 2). Changing asparagine to serine eliminates
this site of posttranslational modification and this may affect
the function of the protein. Interestingly, at position 306 there
is an asparagine only in the human SP4 sequence while in the
mouse, rat, dog and cow there is a threonine. Therefore, as-
paragine is not a conserved residue. With regard to the GNB1
intronic variant, it is not in a splice site or a consensus branch
point, but it may be in a heretofore-unknown regulatory re-
gion.
For the intronic GNB1 variant, a DNA fragment includ-
ing exon 2, intron 2 (carrying the variant), and exon 3 would
have to be expressed to determine if this variant caused a splic-
ing problem. However, the sequences adjacent to the A-G sub-
stitution do not correspond to consensus branch point se-
quences. Another possibility is that the A-G substitution would
disrupt an enhancer or a repressor sequence causing altered
expression of the GNB1 gene. Although there is no direct evi-
dence that the Asn306Ser mutation in the SP4 gene and the
intron 2 A-G variant of the GNB1gene together are respon-
sible for disease in the affected individuals, digenic disease
cannot be ruled out without further testing the pathogenicity
of the alleles. It is certainly plausible that the protein products
of a phototransduction gene like GNB1 and a transcription
factor that may influence its expression like SP4 can together
cause digenic disease when one allele of each carries a muta-
tion.
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